Search for other papers by Xiaoya Zheng in
Google Scholar
PubMed
Search for other papers by Heng Xiao in
Google Scholar
PubMed
Search for other papers by Jian Long in
Google Scholar
PubMed
Search for other papers by Qiang Wei in
Google Scholar
PubMed
Search for other papers by Liping Liu in
Google Scholar
PubMed
Search for other papers by Liping Zan in
Google Scholar
PubMed
Search for other papers by Wei Ren in
Google Scholar
PubMed
-related adverse events (irAEs) ( 2 ). Among endocrine irAEs, thyroid dysfunction occurs most frequently in patients treated with anti-PD-1 therapy ( 3 , 4 ). The mechanism by which anti-PD-1 treatment causes abnormal thyroid function is not yet fully understood
Instituto de Investigación en Biomedicina de Buenos Aires – CONICET, Departamento de Fisiología, Partner Institute of the Max Planck Society, Buenos Aires, Argentina
Search for other papers by Fernando Aprile-Garcia in
Google Scholar
PubMed
Instituto de Investigación en Biomedicina de Buenos Aires – CONICET, Departamento de Fisiología, Partner Institute of the Max Planck Society, Buenos Aires, Argentina
Search for other papers by María Antunica-Noguerol in
Google Scholar
PubMed
Search for other papers by Maia Ludmila Budziñski in
Google Scholar
PubMed
Search for other papers by Ana C Liberman in
Google Scholar
PubMed
Instituto de Investigación en Biomedicina de Buenos Aires – CONICET, Departamento de Fisiología, Partner Institute of the Max Planck Society, Buenos Aires, Argentina
Search for other papers by Eduardo Arzt in
Google Scholar
PubMed
/inflammatory responses: interactions between nuclear factor-κB and steroid receptor-signaling pathways . Endocrine Reviews 1999 20 435 – 459 . ( doi:10.1210/er.20.4.435 ). 15 Besedovsky H del Rey A Sorkin E Dinarello CA . Immunoregulatory feedback between interleukin-1
Search for other papers by Karim Gariani in
Google Scholar
PubMed
Diabetes Center, Faculty of Medicine, University of Geneva, Geneva, Switzerland
Search for other papers by François R Jornayvaz in
Google Scholar
PubMed
. Endocrine causes of NASH Type 2 diabetes/insulin resistance NAFLD is a major risk factor for the development of type 2 diabetes, most likely because of its strong association with hepatic insulin resistance ( 34 ). This is notably due to the fact that
Search for other papers by Keiko Ohkuwa in
Google Scholar
PubMed
Search for other papers by Kiminori Sugino in
Google Scholar
PubMed
Search for other papers by Ryohei Katoh in
Google Scholar
PubMed
Search for other papers by Mitsuji Nagahama in
Google Scholar
PubMed
Search for other papers by Wataru Kitagawa in
Google Scholar
PubMed
Search for other papers by Kenichi Matsuzu in
Google Scholar
PubMed
Search for other papers by Akifumi Suzuki in
Google Scholar
PubMed
Search for other papers by Chisato Tomoda in
Google Scholar
PubMed
Search for other papers by Kiyomi Hames in
Google Scholar
PubMed
Search for other papers by Junko Akaishi in
Google Scholar
PubMed
Search for other papers by Chie Masaki in
Google Scholar
PubMed
Search for other papers by Kana Yoshioka in
Google Scholar
PubMed
Search for other papers by Koichi Ito in
Google Scholar
PubMed
Introduction Parathyroid carcinoma (PC) is a rare endocrine tumor that accounts for <0.5–5% of patients with primary hyperparathyroidism ( 1 , 2 , 3 , 4 ). Complete surgical resection is the only curative treatment for PC. To prevent local
Willem-Alexander Children’s Hospital, Department of Pediatrics, Division of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands
Search for other papers by H Vlaardingerbroek in
Google Scholar
PubMed
Search for other papers by E L T van den Akker in
Google Scholar
PubMed
Search for other papers by A C S Hokken-Koelega in
Google Scholar
PubMed
Introduction Worldwide, obesity is reaching an epidemic state. In a vast majority of patients with obesity, lifestyle factors, such as too much food consumption and no or infrequent exercise, play a major role; in a small percentage of
Search for other papers by Anastasia Ibba in
Google Scholar
PubMed
Search for other papers by Francesca Corrias in
Google Scholar
PubMed
Search for other papers by Chiara Guzzetti in
Google Scholar
PubMed
Search for other papers by Letizia Casula in
Google Scholar
PubMed
Search for other papers by Mariacarolina Salerno in
Google Scholar
PubMed
Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-infantili, Università di Genova, Genova, Italy
Search for other papers by Natascia di Iorgi in
Google Scholar
PubMed
Search for other papers by Gianluca Tornese in
Google Scholar
PubMed
Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-infantili, Università di Genova, Genova, Italy
Search for other papers by Giuseppa Patti in
Google Scholar
PubMed
Search for other papers by Giorgio Radetti in
Google Scholar
PubMed
Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-infantili, Università di Genova, Genova, Italy
Search for other papers by Mohamad Maghnie in
Google Scholar
PubMed
Search for other papers by Marco Cappa in
Google Scholar
PubMed
Search for other papers by Sandro Loche in
Google Scholar
PubMed
. ( https://doi.org/10.1007/BF03344184 ) 15 Blum WF Alherbish A Alsagheir A El Awwa A Kaplan W Koledova E Savage MO The growth hormone–insulin-like growth factor-I axis in the diagnosis and treatment of growth disorders . Endocrine
Search for other papers by Luigia Cinque in
Google Scholar
PubMed
Search for other papers by Angelo Sparaneo in
Google Scholar
PubMed
Search for other papers by Antonio S Salcuni in
Google Scholar
PubMed
Search for other papers by Danilo de Martino in
Google Scholar
PubMed
Search for other papers by Claudia Battista in
Google Scholar
PubMed
Search for other papers by Francesco Logoluso in
Google Scholar
PubMed
Search for other papers by Orazio Palumbo in
Google Scholar
PubMed
Search for other papers by Roberto Cocchi in
Google Scholar
PubMed
Search for other papers by Evaristo Maiello in
Google Scholar
PubMed
Search for other papers by Paolo Graziano in
Google Scholar
PubMed
Search for other papers by Geoffrey N Hendy in
Google Scholar
PubMed
Search for other papers by David E C Cole in
Google Scholar
PubMed
Search for other papers by Alfredo Scillitani in
Google Scholar
PubMed
Search for other papers by Vito Guarnieri in
Google Scholar
PubMed
Introduction The multiple endocrine neoplasia type 1 syndrome (MEN1, MIM131100) is primarily characterized by parathyroid, gastro-entero-pancreatic and pituitary tumors ( 1 , 2 ). Less frequently, it is associated with adrenocortical ( 3
Search for other papers by Felix Reschke in
Google Scholar
PubMed
Search for other papers by Torben Biester in
Google Scholar
PubMed
Search for other papers by Thekla von dem Berge in
Google Scholar
PubMed
Search for other papers by Dagmar Jamiolkowski in
Google Scholar
PubMed
Search for other papers by Laura Hasse in
Google Scholar
PubMed
Search for other papers by Francesca Dassie in
Google Scholar
PubMed
Search for other papers by Pietro Maffei in
Google Scholar
PubMed
Search for other papers by Katharina Klee in
Google Scholar
PubMed
Search for other papers by Olga Kordonouri in
Google Scholar
PubMed
Search for other papers by Hagen Ott in
Google Scholar
PubMed
Search for other papers by Thomas Danne in
Google Scholar
PubMed
condition. Consequently, as in certain hereditary endocrine diseases for example, the skin can also provide information about the severity of the underlying disease or can even be indicative of the condition itself. Diseases of endocrine organs often lead to
Search for other papers by Adrian J L Clark in
Google Scholar
PubMed
Search for other papers by Simon Buckmaster in
Google Scholar
PubMed
submitted this year from authors most probably attracted by our increasing Journal Impact Factor™, the broad spectrum of research covered by the journal and our very inexpensive article publication charges. We believe that we have identified and rejected all
Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus C, Denmark
Search for other papers by Esben S Lauritzen in
Google Scholar
PubMed
Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus C, Denmark
Search for other papers by Nikolaj Rittig in
Google Scholar
PubMed
Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus C, Denmark
Search for other papers by Ermina Bach in
Google Scholar
PubMed
Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus C, Denmark
Search for other papers by Niels Møller in
Google Scholar
PubMed
Search for other papers by Mette Bjerre in
Google Scholar
PubMed
Parameswara V Li Y Goetz R Mohammadi M Esser V Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21 . Cell Metabolism 2007 5 415 – 425 . ( doi:10.1016/j.cmet.2007.05.003 ) 6